Yingqin L Li

US Patent:

6991811, Jan 31, 2006

Filed:

May 19, 2000

Appl. No.:

09/575307

Inventors:

Ernesto A. Brovelli - Corona CA, US
Yong Qian - San Diego CA, US
Puri G. David - Moreno Valley CA, US
Kari L. Truax - Hemet CA, US
Yingqin Li - Murrieta CA, US

Assignee:

Access Business Group International LLC - Ada MI

International Classification:

A61K 35/78

US Classification:

424725

Abstract:

The present invention relates to the use of as a cancer chemopreventive agent to block the formation of and to detoxify cancer-causing agents, or carcinogens. More particularly, the present invention relates to the induction of phase II enzymes by and specifically by lipid-soluble fractions isolated from The present invention also contemplates a novel method of extracting the desired lipid-soluble fractions from.

US Patent:

20060275520, Dec 7, 2006

Filed:

May 19, 2006

Appl. No.:

11/437885

Inventors:

Chioma Ikonte - Corona CA, US
Jatinder Rana - Grand Rapids MI, US
David Fast - Grand Rapids MI, US
Yingqin Li - Murrieta CA, US

International Classification:

A61K 36/725
A61K 36/70
A61K 36/65

US Classification:

424773000, 424774000, 424778000, 424451000, 424440000, 424464000

Abstract:

The present invention relates to compositions for treating insomnia or sleeplessness. The compositions of the present invention comprise extracts of white peony root and in particular comprise paeoniflorin, either alone or in combination with at least one of jujube extract, radix polygala extract, and passion flower extract. The compositions of the present invention bind to GABA receptors and work synergistically to shorten the time needed to fall asleep and to improve the quality of sleep by reducing awakenings during sleep and increasing the duration of sleep.

US Patent:

62178784, Apr 17, 2001

Filed:

Aug 13, 1999

Appl. No.:

9/373943

Inventors:

Gopi R. Menon - Riverside CA
Ernesto Brovelli - Corona CA
Jatinder Rana - Grand Rapids MI
Yingqin Li - Murrieta CA

Assignee:

Amway Corporation - Ada MI

International Classification:

A61K 3578

US Classification:

4241951

Abstract:

A process for producing an Echinacea powder having an increased amount of the cichoric acid present in the harvested Echinacea plant material. The process includes the following steps: 1) milling the harvested Echinacea plant material to reduce the particle size, 2) blanching the milled plant material, 3) recovering the juice from the blanched material, 4) concentrating the juice to have at least about a 20% soluble solids content, and 5) drying the juice to produce the Echinacea powder having a moisture content of less than about 8%. The blanching step enhances the juice recovery from the Echinacea plant material. The Echinacea powder can be tableted or combined with other nutrients in a dry supplement form.

US Patent:

20170281703, Oct 5, 2017

Filed:

Mar 21, 2017

Appl. No.:

15/464695

Inventors:

- Ada MI, US
John F. Rebhun - Greenville MI, US
Samantha Roloff - Grand Rapids MI, US
Yingqin Li - Murrieta CA, US
Dawna Venzon - Brea CA, US

International Classification:

A61K 36/484
A61K 31/12
A61K 31/353

Abstract:

A nutritional supplement comprises components (A), (B) and (C), and optionally, additional component(s) (D). The nutritional supplement can activate a subject's antioxidant system, more specifically the subject's antioxidant response element (ARE). In one embodiment, the nutritional supplement comprises: (A) glabridin; (B) licochalcone A; and (C) licorice root flavonoids. In another, the nutritional supplement comprises: (A) a first licorice root extract comprising glabridin; (B) a second licorice root extract comprising licochalcone A; and (C) a third licorice root extract comprising flavonoids. Components (A), (B) and (C) are in a combined amount sufficient to activate the subject's antioxidant system after ingestion. In addition, components (A), (B) and (C) are present in a weight ratio (A:B:C) such that their combined effect is greater than the sum of their separate effects regarding activation of the subject's antioxidant system after ingestion of the nutritional supplement.